Ambalal Sarabhai Enterprises: Board approves FY26 results, re-appointments

Ambalal Sarabhai Enterprises Ltd's board meeting on May 21, 2026, approved the audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. They also re-appointed Gautam Joshi & Co. as internal auditor for FY 2026-27 and approved the draft notice for the 48th Annual General Meeting to be held on July 30, 2026, via video conferencing. The board recommended the re-appointment of Kartikeya V. Sarabhai as Executive Chairman, Chaula M. Shastri as Whole-time Director, and Mohal K. Sarabhai as Managing Director, and approved inter-corporate loans to Asence Pharma, Synbiotics, and Systronics India.